{
  "run_id": "RUN_20260204_132700_1fed028ce5fb",
  "timestamp": "2026-02-04T15:31:32.860187",
  "document": "03_Protocol_ALXN1720-oMG-303.pdf",
  "document_path": "/Users/frederictetard/Projects/ese/gold_data/PAPERS/03_Protocol_ALXN1720-oMG-303.pdf",
  "pipeline_version": "0.8",
  "total_detected": 2,
  "unique_companies": 2,
  "companies": [
    {
      "matched_text": "Alexion Pharmaceuticals",
      "canonical_name": "Alexion",
      "full_name": "Alexion Pharmaceuticals",
      "headquarters": "Boston, USA",
      "parent_company": "AstraZeneca",
      "subsidiaries": [],
      "confidence": 0.95,
      "context": "Alexion Pharmaceuticals",
      "page": 1,
      "lexicon_source": "pharma_companies_lexicon.json"
    },
    {
      "matched_text": "AstraZeneca",
      "canonical_name": "AstraZeneca",
      "full_name": "AstraZeneca PLC",
      "headquarters": "Cambridge, UK",
      "parent_company": null,
      "subsidiaries": [
        "Alexion"
      ],
      "confidence": 0.95,
      "context": "AstraZeneca",
      "page": 1,
      "lexicon_source": "pharma_companies_lexicon.json"
    }
  ]
}